IMMUNOHISTOCHEMISTRY: HER-2 / ERBB2 BREAST
113 Ratings
Rs 10,720 Rs 8,000
25 % OFF
HER-2 OVEREXPRESSION IN BREAST CARCINOMA IS ASSOCIATED WITH SHORTER DISEASE FREE INTERVAL AND SHORTER OVERALL SURVIVAL. HER-2 POSITIVE BREAST CANCERS TEND TO BE MORE AGGRESSIVE BUT TREATMENTS THAT TARGET HER-2 ARE VERY EFFECTIVE. EXPRESSION OF HER-2 PROTEIN IS AN INDICATION FOR SPECIFIC THERAPY WITH TRASTUZUMAB / HERCEPTIN / PERTUZUMAB / NERATINIB IN PATIENTS WITH BREAST CANCER.
Why book with us?
-
Free and On Schedule Sample Collection
-
24/7 Service
-
Affordable
-
Quick and Accurate Reports
SUBMIT TISSUE IN 10% FORMAL-SALINE OR FORMALIN FIXED PARAFFIN EMBEDDED TISSUE BLOCK. SHIP AT ROOM TEMPERATURE. PROVIDE A COPY OF THE HISTOPATHOLOGY REPORT, SITE OF BIOPSY AND CLINICAL HISTORY.
IHC
REPORT ON 4TH DAY EVENING 7PM
PROVIDE A COPY OF THE HISTOPATHOLOGY REPORT, SITE OF BIOPSY AND CLINICAL HISTORY.
